Search research articles
Contact Us
Filters
Showing results (241-250 of 487) with videos related to
Page
of 49
Sort By:
NPJ Precision Oncology
|
December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Niamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Discovery Medicine
|
March 1, 2015
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine
|
January 1, 2015
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine
|
January 1, 2015
Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Oncotarget
|
October 30, 2015
Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine
Vivek Subbiah, Michael J Wagner, Mary F McGuire, et al.
Discovery Medicine
|
March 1, 2015
Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
JCO Clinical Cancer Informatics
|
November 14, 2025
RadOncRAG: A Novel Retrieval-Augmented Generation Framework Improves Large Language Model Benchmark Performance in Radiation Oncology
Nikhil Gautam Thaker, Navid Redjal, Adam Dicker, et al.
NPJ Precision Oncology
|
January 29, 2026
A unified framework for pre-screening and screening tools in oncology clinical trials
Denis Horgan, Joe Paulson, Arturo Loaiza-Bonilla, et al.
Diagnosis (Berlin, Germany)
|
December 17, 2024
Challenges and barriers for the adoption of personalized medicine in Europe: the case of Oncotype DX Breast Recurrence Score<sup>®</sup> test
Denis Horgan, Paul Hofman, Patrizio Giacomini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma
Vivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Page
of 49
Search research articles
Search
Showing results (241-250 of 487) with videos related to
Sort By:
Page
of 49
NPJ Precision Oncology
|
December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Niamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Discovery Medicine
|
March 1, 2015
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine
|
January 1, 2015
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine
|
January 1, 2015
Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Oncotarget
|
October 30, 2015
Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine
Vivek Subbiah, Michael J Wagner, Mary F McGuire, et al.
Discovery Medicine
|
March 1, 2015
Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome
Rishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
JCO Clinical Cancer Informatics
|
November 14, 2025
RadOncRAG: A Novel Retrieval-Augmented Generation Framework Improves Large Language Model Benchmark Performance in Radiation Oncology
Nikhil Gautam Thaker, Navid Redjal, Adam Dicker, et al.
NPJ Precision Oncology
|
January 29, 2026
A unified framework for pre-screening and screening tools in oncology clinical trials
Denis Horgan, Joe Paulson, Arturo Loaiza-Bonilla, et al.
Diagnosis (Berlin, Germany)
|
December 17, 2024
Challenges and barriers for the adoption of personalized medicine in Europe: the case of Oncotype DX Breast Recurrence Score<sup>®</sup> test
Denis Horgan, Paul Hofman, Patrizio Giacomini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma
Vivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Page
of 49